Yeul Hong Kim - Concepedia

Author

Yeul Hong Kim

Also Known As

George Kannourakis, Gianmauro Numico, Hendrik Kröning, Jian Su, Kim, Y.H.;Shin, K.H.;, S. J. Kim, Saehoon Kim, Wasaburo Koizumi, Wu-Chou Su, Y -H Kim

490

Publications

13.2K

Citations

H-Index

178

Concepts

All Affiliations

Korea University Korea University Medical Center Seoul National University Seoul National University Hospital Samsung Medical Center

About

Yeul Hong Kim is an author at Korea University specializing in medicine, cancer research, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	95	6.5K
2	Health Sciences	15	19	657
3	Public Health	12	12	705
4	Engineering	10	10	261
5	Natural Sciences	2	2	260

Yeul Hong Kim

201

Publications

11.5K

Citations

H-Index

Page 1

	Year	Citations
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Yung‐Jue Bang, Young‐Woo Kim, Han‐Kwang Yang, The Lancet Surgical OncologyGastrointestinal OncologyMedicineAdjuvant CapecitabineGastroenterology	2012	1.7K
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang, The Lancet Pembrolizumab Versus PaclitaxelGastrointestinal OncologyMedicineGastroenterologySurgery	2018	1.3K
Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study Atsushi Ohtsu, Jaffer A. Ajani, Yu-Xian Bai, Journal of Clinical Oncology	2013	487
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia Qing Lan, Chao A. Hsiung, Keitaro Matsuo, Nature Genetics Genome-wide Association StudyTobacco ControlEpidemiologyMedicineGenetics	2012	346
Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer Yung‐Jue Bang, Seock‐Ah Im, Keun‐Wook Lee, Journal of Clinical Oncology	2015	289
Measurement of protein turnover rates by heavy water labeling of nonessential amino acids Robert Busch, Yeul Hong Kim, Richard A. Neese, Biochimica et Biophysica Acta (BBA) - General Subjects Protein ChemistryNonessential Amino AcidsBiochemistryProtein FoldingMedicine	2006	249
The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia Chao A. Hsiung, Qing Lan, Yun‐Chul Hong, PLoS Genetics	2010	210
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types Joshua N. Sampson, William A. Wheeler, Meredith Yeager, JNCI Journal of the National Cancer Institute	2015	189
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial Daniel V.T. Catenacci, Yoon‐Koo Kang, Haeseong Park, The Lancet Oncology OncologyEsophageal CancerGastrointestinal OncologyPathologyImmune Checkpoint Inhibitor	2020	186
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome Mitchell J. Machiela, Weiyin Zhou, Eric Karlins, Nature Communications	2016	161

Page 1